Feline infectious peritonitis
GPTKB entity
Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:disease
|
| gptkbp:affects |
cats
|
| gptkbp:associated_with |
FIP virus
cattery environments |
| gptkbp:caused_by |
Feline coronavirus
|
| gptkbp:clinical_trial |
gptkb:anemia
jaundice diarrhea respiratory distress neurological signs |
| gptkbp:death |
high
|
| gptkbp:diagnosis |
gptkb:animals
serology PCR test |
| gptkbp:epidemiology |
seasonal outbreaks
global distribution higher incidence in purebred cats increased risk in overcrowded conditions prevalent in shelters |
| gptkbp:first_described_by |
1960s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Feline infectious peritonitis
|
| gptkbp:incubation_period |
2 to 14 days
|
| gptkbp:is_common_in |
young cats
immunocompromised cats |
| gptkbp:prevention |
no vaccine available
|
| gptkbp:research |
ongoing
|
| gptkbp:research_areas |
therapeutic agents
vaccine development diagnostic methods |
| gptkbp:research_focus |
immune response
pathogenesis |
| gptkbp:risk_factor |
stress
age genetic predisposition multi-cat households |
| gptkbp:symptoms |
weight loss
fever dehydration lethargy loss of appetite fluid accumulation abdominal swelling behavior changes |
| gptkbp:transmission |
not contagious between cats
|
| gptkbp:treatment |
gptkb:immunotherapy
variable antibiotics nutritional support supportive care corticosteroids poor prognosis immunosuppressive drugs some cases improve |
| gptkbp:type |
dry form
wet form |
| gptkbp:bfsParent |
gptkb:Feline_Immunodeficiency_Virus
|
| gptkbp:bfsLayer |
5
|